meddevicedb.com FDA Device Reference

PL-1 Skin Treatment System

K213726 Class II Traditional
Decision Date
2022-06-28
Sponsor / Applicant
AVAVA, Inc.

Technical Specification

510(k) Submission ID K213726
Product Code GEX
Medical Specialty / Panel General, Plastic Surgery
Regulation Citation 21 CFR 878.4810
Decision Date 2022-06-28
Clearance Pathway Traditional

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

PL-1 Skin Treatment System received FDA 510(k) clearance under submission number K213726, sponsored by AVAVA, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the General, Plastic Surgery review panel. The statutory decision date of record is 2022-06-28.

Classification & Regulation

This clearance is catalogued under FDA product code GEX and 21 CFR 878.4810, within the General, Plastic Surgery review panel as a Class II device.